
History Shows us we Don’t Need Billionaire Doctors to Make Medical Breakthroughs
Our tax codes incentivize medical entrepreneurs to go for gold while patients are left juggling what’s best for them versus what they can afford.
Our tax codes incentivize medical entrepreneurs to go for gold while patients are left juggling what’s best for them versus what they can afford.
Congress can only ignore the blatantly dishonest practice of offshore tax evasion for so long.
Big Pharma company Pfizer is currently evading $40 billion in tax obligations and trying to make that permanent through a tax-dodging marriage with Irish firm Allergen.
Congress should open the pathways for doctors and patients to participate in more innovative treatments.
Pharma Bro’s one-of-a-kind album purchase exemplifies how the ultra rich are polluting our culture.
While the rest of us pay the sticker price, lawmakers are considering a special deluxe tax rate for giant corporations.
IPS’ Global Economy and Foreign Policy In Focus projects co-sponsor this a shocking exposé of how pharmaceutical companies use patent law to keep profits unconscionably high even at the expense of peoples’ lives.
Privilege rules at U.S. hospitals and patients are at the mercy of powerful players who operate with impunity.
Attorneys trying to prevent the cruelty of a botched execution are challenging states’ efforts to conduct experiments on their clients with new execution drugs.
The Walmart case is only one example of the Supreme Court’s growing tendency to side with the interests of big corporations over the rights of ordinary citizens.
A Pfizer settlement in a Nigerian lawsuit turns ugly.